Hubei Feilihua Quartz Glass stock
300395.SZSHZHubei Feilihua Quartz Glass Co., Ltd., Basic MaterialsISIN CNE100001XR9
55Score 55 out of 100, Neutral
Price and trend
39 / 100
Price history
−6.7% in one yearThe chart shows daily closes over 12 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 29% below it.
Since August 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 43).
The price is 53% below its 52-week high. Largest decline in 12 years: 66% (October 2022 to February 2024).
Chart figures for advanced users
- SMA 50$12.53
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$15.17
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)43
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$9.38
- The lowest closing price of the last twelve months.
- Resistance$22.71
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Hubei Feilihua Quartz Glass Co., Ltd. belongs to the Chemicals (Specialty) industry (China) and, with a market value of $5.62B, is number 56 of 106 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $302.38M (up 15.8% year on year) and earnings of $66.46M (up 41%).
- MEQIRI Score 55 out of 100 (Neutral): rank 255 of 461 in Basic Materials, median 57.
Show more
- The P/E is 63.8 (Chemicals (Specialty) median 22.5, own median of recent years 49.6).
- Our model puts fair value at $3.43, with the price 212% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Analysts expect strong earnings growthUp 29.2% a year through 2028 (estimates from 2 analysts).Growth 83
- More cash than debtCash $233.32M, financial debt $111.25M.Stability 76
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 54
Weaknesses
- Above fair valuePrice 212% above the fair value of $3.43.Valuation 20
- Richly valuedP/E 63.8, Chemicals (Specialty) median 22.5, own median 49.6.Valuation 20
- Negative free cash flowFree cash flow −$69.11M over the last 12 months.Fundamentals 54
Its standout strengths are growth and stability, while valuation and momentum hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $2.29 and expensive above $6.87 (uncertainty very high, based on the price swings of the past year).
The two parts of the fair value come to $3.09 (cash-flow model) and $3.78 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 7.3%. At 8.3% the fair value would be $3.14, at 6.3% it would be $3.88.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (22.5).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 50.1% on the twelve months before. Revenue has grown strongly since 2011, at around 15% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 47%, operating 23%, net 22%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 28 Apr 2027in 166 days
- Last reported
- 24 Oct 2026EPS reported $0.05
Analyst estimates
Earnings estimates have barely changed since 25 Oct 2026.
- Earnings per share
- $0.190.0%
- Revenue
- $453.79M0.0%
- Earnings per share
- $0.280.0%
- Revenue
- $624.45M0.0%
MEQIRI has stored the estimates since 25 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Hubei Feilihua Quartz Glass
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 55
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Shenzhen Capchem Technology300037.SZ $6.07B63
- Berger Paints IndiaBERGEPAINT.NS $5.94B68
- Kingboard Holdings0148.HK $5.87B51
- Inner Mongolia Junzheng Energy & Chemical Group601216.SS $5.8B52
- Gujarat FluorochemicalsFLUOROCHEM.NS $5.62B59
- BalchemBCPC $5.49B72
- Navin Fluorine InternationalNAVINFLUOR.NS $5.44B79
- Sumitomo Chemical4005.T $5.42B54
ETFs that hold Hubei Feilihua Quartz Glass
Held by 27 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Xtrackers Harvest CSI A500 UCITS ETF 1DAH50 | 0.12% | 0.65% | €10.81M |
| iShares MSCI China A UCITS ETF36BZ | 0.09% | 0.40% | €1.81B |
| WisdomTree Emerging Markets ex-State Owned Enterprises UCITS ETF AccumUSDXSOE | 0.03% | 0.32% | €17.98M |
Show 5 more
| Franklin FTSE China UCITS ETFFLXC | 0.01% | 0.19% | €1.43B |
| HSBC MSCI China UCITS ETFH4ZP | 0.01% | 0.28% | €865.89M |
| iShares MSCI EM CTB Enhanced ESG UCITS ETFEDM2 | 0.01% | 0.18% | €7.25B |
| Amundi Core MSCI Emerging Markets UCITS ETF EUR DistAEMD | 0.00% | 0.18% | €9.52B |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.00% | 0.17% | €5.24B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 28 Feb 2023)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.